In a nutshell This study reviewed recent research on the long-term health related quality of life for patients with chronic myeloid leukemia (CML). The authors concluded that while CML patients may now expect to lead long lives, more attention needs to focus on managing treatment side effects. Some background The prognosis for patients with CML...
Read More
In a nutshell This study examined the effectiveness of bosutinib (Bosulif), a tyrosine kinase inhibitor (TKI), after previous treatment with multiple TKIs for chronic myeloid leukemia (CML). Researchers concluded that bosutinib was associated with good effectiveness for CML patients for whom previous TKIs have failed. Some background Targeted...
Read More
In a nutshell This study examined treatment outcomes in patients with chronic myeloid leukemia (CML) treated with second-line tyrosine kinase inhibitors (TKIs). Researchers concluded that treatment responses with second-line TKIs are stable over time. Patients with less favorable treatment outcomes can be identified early during therapy. Some...
Read More
